Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jan-Peter Andreas Mayer"'
Autor:
Maria Carmen Ochoa, Luna Minute, Ascensión López, Elisabeth Pérez-Ruiz, Celia Gomar, Marcos Vasquez, Susana Inoges, Iñaki Etxeberria, Inmaculada Rodriguez, Saray Garasa, Jan-Peter Andreas Mayer, Peter Wirtz, Ignacio Melero, Pedro Berraondo
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Enhancement of antibody-dependent cellular cytotoxicity (ADCC) may potentiate the antitumor efficacy of tumor-targeted monoclonal antibodies. Increasing the numbers and antitumor activity of NK cells is a promising strategy to maximize the ADCC of st
Externí odkaz:
https://doaj.org/article/eb4a7b04d61742b58969d7204c422992
Autor:
Yoko Oda, Hiroyuki Hanzawa, René Bartz, Mizuki Takahashi, Tanja Lange, Toshinori Agatsuma, Reimi Kawaida, Jan-Peter Andreas Mayer, Toshiaki Ohtsuka, Alberto J Martinez, Roger W. Chapman, Ichiro Watanabe, Johannes Bange, Yoshinori Kashimoto, Shinko Hayashi, Shuntaro Saito, Reimar Abraham, Masaharu Hanai, Emi Imai, Mauricio Redondo-Müller, Katrin Gruner, Hironobu Komori, Dieter Häussinger, Keisuke Fukuchi, Peter Wirtz
Publikováno v:
Molecular cancer therapeutics. 18(10)
The FGFR4/FGF19 signaling axis is overactivated in 20% of liver tumors and currently represents a promising targetable signaling mechanism in this cancer type. However, blocking FGFR4 or FGF19 has proven challenging due to its physiological role in s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bb5e803f3816619699a45efa70e121b
https://pubmed.ncbi.nlm.nih.gov/31350344
https://pubmed.ncbi.nlm.nih.gov/31350344
Autor:
Jan-Peter Andreas Mayer, Elisabeth Pérez-Ruiz, Iñaki Etxeberria, Peter Wirtz, Pedro Berraondo, Marcos Vasquez, Saray Garasa, Maria C. Ochoa, Luna Minute, Celia Gomar, Ascensión López, Inmaculada Rodriguez, Ignacio Melero, Susana Inogés
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Enhancement of antibody-dependent cellular cytotoxicity (ADCC) may potentiate the antitumor efficacy of tumor-targeted monoclonal antibodies. Increasing the numbers and antitumor activity of NK cells is a promising strategy to maximize the ADCC of st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::989e1199b458d9fa75bc9731064a5fc5
https://doi.org/10.1080/2162402x.2017.1393597
https://doi.org/10.1080/2162402x.2017.1393597